In a recent study, the blood U-p53 protein has been proposed as a robust biomarker outperforming other well-known AD biomarkers, such as Aβ PET scan, for identifying people at risk of developing AD 6 years before the onset of symptoms (AUC > 98%) [14]. The gene discussed is TP53; the disease is Alzheimer disease.